Cargando…

Can pregnancy-associated plasma protein-A be a marker for the assessment of atherosclerosis risk in patients with chronic plaque psoriasis?

INTRODUCTION: Psoriasis is an immune-mediated chronic inflammatory dermatosis. Several studies have shown that patients with psoriasis have a much greater risk of cardiovascular diseases than the normal population. The chronic inflammation observed in psoriasis is thought to have a role in the devel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Polat, Mualla, Bugdayci, Guler, Sahin, Asli, Kaya, Hatice, Sezer, Tuna, Ozturk, Serkan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2016
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110623/ https://www.ncbi.nlm.nih.gov/pubmed/27881939 http://dx.doi.org/10.5114/ada.2016.62839

Ejemplares similares

Assessment of subclinical cardiac damage in chronic plaque psoriasis patients: a case control study
por: Ozden, Hatice Kaya, et al.
Publicado: (2016)

Coexistence of lichen planus follicularis tumidus and Hashimoto's thyroiditis
por: Ozden, Hatice Kaya, et al.
Publicado: (2017)

Evaluation of pregnancy-associated plasma protein-A and some inflammation markers for atherosclerosis in psoriasis patients
por: Akyurek, Fikret, et al.
Publicado: (2021)

Subclinical atherosclerosis in patients with psoriasis
por: Balta, Ilknur, et al.
Publicado: (2015)

Prolidase activity in chronic plaque psoriasis patients
por: Sürücü, Hacer Altın, et al.
Publicado: (2015)

Oyster-shaped hyperkeratotic plaques on the penis
por: Sezer, Engin, et al.
Publicado: (2015)

Psoriasis and Atherosclerosis—Skin, Joints, and Cardiovascular Story of Two Plaques in Relation to the Treatment with Biologics
por: Wierzbowska-Drabik, Karina, et al.
Publicado: (2021)

Emopamil Binding Protein Mutation in Conradi-Hünermann-Happle Syndrome Representing Plaque-Type Psoriasis
por: Ozyurt, Kemal, et al.
Publicado: (2015)

Guselkumab for plaque psoriasis
Publicado: (2019)

Bimekizumab for plaque psoriasis
Publicado: (2022)

Enhanced Inflammation and Nitrosative Stress in the Saliva and Plasma of Patients with Plaque Psoriasis
por: Skutnik-Radziszewska, Anna, et al.
Publicado: (2020)

Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability
por: Shindo, Akihiro, et al.
Publicado: (2014)

Can patient-physician interview skills be implemented with peer simulated patients?
por: Tengiz, Funda İfakat, et al.
Publicado: (2022)

Safety and Efficacy of a Novel Combination Cream (GN-037) in Healthy Volunteers and Patients with Plaque Psoriasis: A Phase 1 Trial
por: Sezer, Zafer, et al.
Publicado: (2023)

A combination of plasma DAO and citrulline levels as a potential marker for acute mesenteric ischemia
por: Çakmaz, Rıdvan, et al.
Publicado: (2013)

Apremilast in the Treatment of Plaque Psoriasis: Differential Use in Psoriasis
por: Gao, Jia C, et al.
Publicado: (2022)

Etanercept in the treatment of plaque psoriasis
por: Nguyen, Thao U, et al.
Publicado: (2009)

Infliximab for the treatment of plaque psoriasis
por: Gall, Jennifer S, et al.
Publicado: (2008)

Habits of Using Social Media and the Internet in Psoriasis Patients
por: Aslan Kayıran, Melek, et al.
Publicado: (2022)

The Relation between Atherosclerosis Plaque Composition and Plaque Rupture
por: Babaniamansour, Parto, et al.
Publicado: (2020)

Increased Risk of Atrial and Ventricular Arrhythmia in Long-Lasting Psoriasis Patients
por: Simsek, Hakki, et al.
Publicado: (2013)

Plasma Testosterone Levels and Atherosclerotic Plaque Gene Expression in Men With Advanced Atherosclerosis
por: Groepenhoff, Floor, et al.
Publicado: (2021)

Immunity: Psoriasis comorbid with atherosclerosis
por: Liu, Chunping, et al.
Publicado: (2022)

The effect of extremely high glucose concentrations on 21 routine chemistry and thyroid Abbott assays: interference study
por: Çuhadar, Serap, et al.
Publicado: (2016)

The safety of etanercept for the treatment of plaque psoriasis
por: Papp, Kim A
Publicado: (2007)

Ustekinumab in the therapy of chronic plaque psoriasis
por: O’Neill, Jenna L, et al.
Publicado: (2009)

Infliximab in the treatment of plaque type psoriasis
por: Saraceno, Rosita, et al.
Publicado: (2009)

Bacterial colonization of psoriasis plaques. Is it relevant?
por: Marcus, Eva, et al.
Publicado: (2011)

Stigmatization among Patients with Plaque Psoriasis
por: Jankowiak, Barbara, et al.
Publicado: (2023)

Inhibitory Effect of Sodium Alginate Nanoemulsion Coating Containing Myrtle Essential Oil (Myrtus communis L.) on Listeria monocytogenes in Kasar Cheese
por: Polat Yemiş, Gökçe, et al.
Publicado: (2022)

Plaque Rupture in Coronary Atherosclerosis Is Associated With Increased Plaque Structural Stress
por: Costopoulos, Charis, et al.
Publicado: (2017)

Biomarkers of subclinical atherosclerosis in patients with psoriasis
por: Kaiser, Hannah, et al.
Publicado: (2021)

Markers of Inflammation Associated with Plaque Progression and Instability in Patients with Carotid Atherosclerosis
por: Ammirati, Enrico, et al.
Publicado: (2015)

Efficacy of Methotrexate in patients with plaque type psoriasis
por: Haider, Sabiqa, et al.
Publicado: (2014)

Multiple keratoacanthomas developing in healing plaques of Psoriasis
por: Relhan, Vineet, et al.
Publicado: (2013)

Use of clobetasol in lacquer for plaque psoriasis treatment
por: da Silva, Suze Aparecida, et al.
Publicado: (2016)

Treating pediatric plaque psoriasis: challenges and solutions
por: Thomas, Jayakar, et al.
Publicado: (2016)

The content validity of the PSS in patients with plaque psoriasis
por: Rentz, A. M., et al.
Publicado: (2017)

Chronic erythema nodosum with koebnerization to plaque psoriasis()()
por: Smith, Mary Patricia, et al.
Publicado: (2019)

Secukinumab in the Treatment of Plaque Psoriasis in Patients with Malignancy
por: Gambardella, Alessio
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r358hlm02a8reo4ak5b43ak39r